ENTITY
Giant Biogene Holding

Giant Biogene Holding (2367 HK)

57
Analysis
Consumer StaplesChina
Giant Biogene Holding Co., Ltd researches, develops, manufactures, and distributes, and markets skin treatment products. The Company produces recombinant collagen and rare ginsenosides skin treatment products, functional foods, and other products. Giant Biogene Holding conducts businesses in China.
more
Refresh
bearishGiant Biogene Holding 02 May 2023 09:57

Giant Biogene IPO Lock-Up - US$1.7bn Lockup Release Will Increase Free Float by 14x

Giant Biogene raised around US$70m in its Hong Kong IPO, after having downsized the deal and priced it at the low-end. Its six-month lockup will...

Logo
Sumeet Singh
272 Views
Share
bearishGiant Biogene Holding 17 Mar 2023 08:55

Giant Biogene Holding (2367.HK) - The Situation May Not Be as Rosy as It Looks

After Giant Biogene has been added to Hong Kong Stock Connect, liquidity would improve a lot. But lower-than-expected market space, competition and...

Share
bullishGiant Biogene Holding 03 Nov 2022 15:35

Giant Biogene: Thoughts on First Day Trading

Biogene priced its IPO at the bottom of the range due to lower demand as current market volatility has resulted in lower investor appetite. IPO is...

bullishGiant Biogene Holding 03 Nov 2022 09:50

Giant Biogene IPO Trading - Demand Was Relatively Better but Still Weak

Giant Biogene (GB) raised around US$70m by pricing its  HK IPO at the low-end. In this note we talk about the trading dynamics.

Logo
Sumeet Singh
190 Views
Share
bullishGiant Biogene Holding 30 Oct 2022 07:57

ECM Weekly (30th Oct 2022) - Giant Biogene, Sunshine, I-Tail, Global Health, Lygend, Fusion, Blibli

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
Sumeet Singh
262 Views
Share
x